Welcome to LookChem.com Sign In|Join Free

CAS

  • or

128346-20-3

Post Buying Request

128346-20-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

128346-20-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 128346-20-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,3,4 and 6 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 128346-20:
(8*1)+(7*2)+(6*8)+(5*3)+(4*4)+(3*6)+(2*2)+(1*0)=123
123 % 10 = 3
So 128346-20-3 is a valid CAS Registry Number.

128346-20-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester

1.2 Other means of identification

Product number -
Other names t-BOC-cycloserine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128346-20-3 SDS

128346-20-3Downstream Products

128346-20-3Relevant articles and documents

Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors

Abdelsayed,Ha Duong,Hai,Hémadi,El Hage Chahine,Verbeke,Serradji

, p. 3854 - 3860 (2014)

Chlamydia trachomatis (Ct) is a bacterial human pathogen responsible for the development of trachoma, the worldwide infection leading to blindness, and is also a major cause of sexually transmitted diseases. As iron is an essential metabolite for this bac

Number selective NR2B antagonists

-

Paragraph 0059; 0065-0069, (2018/07/28)

The present disclosure provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) compounds are ligands for NR2B N-Methyl-D-aspartate (NMD A) receptor and thereby making them useful for the treatment of various disord

Kinase inhibitor compounds

-

Page/Page column 32, (2009/04/24)

The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128346-20-3